1. Topical Corticosteroid Concerns Among Parents of Children with Psoriasis versus Atopic Dermatitis: A French Multicenter Cross-Sectional Study
- Author
-
Christine Bodemer, Juliette Mazereeuw-Hautier, Anne-Claire Bursztejn, Christine Chiaverini, A. Beauchet, Catherine Droitcourt, A. Phan, Sandra Moawad, Hélène Aubert-Wastiaux, Emmanuel Mahé, Audrey Lasek-Duriez, Sébastien Barbarot, Annabel Maruani, MethodS in Patients-centered outcomes and HEalth ResEarch (SPHERE), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR des Sciences Pharmaceutiques et Biologiques, Université de Nantes (UN)-Université de Nantes (UN), and Université de Tours-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR des Sciences Pharmaceutiques et Biologiques
- Subjects
Male ,Parents ,Cross-sectional study ,[SDV]Life Sciences [q-bio] ,Dermatitis ,Anxiety ,Severity of Illness Index ,030207 dermatology & venereal diseases ,0302 clinical medicine ,Surveys and Questionnaires ,Medicine ,030212 general & internal medicine ,Young adult ,Child ,General Medicine ,Atopic dermatitis ,3. Good health ,Treatment Outcome ,Child, Preschool ,Administration ,Female ,Adult ,medicine.medical_specialty ,Adolescent ,Visual analogue scale ,Dermatology ,Administration, Cutaneous ,Risk Assessment ,Atopic ,Dermatitis, Atopic ,03 medical and health sciences ,Young Adult ,Patient Education as Topic ,Internal medicine ,Psoriasis ,Severity of illness ,Humans ,Preschool ,Glucocorticoids ,business.industry ,Odds ratio ,medicine.disease ,Confidence interval ,Cutaneous ,Cross-Sectional Studies ,Patient Compliance ,Dermatologic Agents ,business ,Follow-Up Studies - Abstract
International audience; BACKGROUND: Atopic dermatitis (AD) and psoriasis are chronic inflammatory cutaneous disorders for which the gold standard treatment is topical corticosteroids. Although fears about topical corticosteroids are known to be a primary cause of poor therapeutic adherence in AD, this has not been evaluated in psoriasis. TOPICOP is a helpful and easy-to-use tool for the evaluation of topical corticosteroid concerns (TCC). It may help clinicians improve adherence to treatment and correct misconceptions. OBJECTIVE: We aimed to compare the TCC of parents of children with psoriasis or AD using the TOPICOP scale and a visual analog scale (VAS). METHODS: We performed a cross-sectional multicenter study in nine French hospitals from 1 October 2015 to 31 May 2016. The~TOPICOP scale was developed for patients with AD and comprises 12 questions to assess patients' worries and beliefs about topical corticosteroids, with a maximum score of 36.~We used a standardized questionnaire to collect epidemiologic and medical data, and the parents completed the TOPICOP scale and VAS (score 0-10). RESULTS: A total of 122 children were enrolled (61 patients in each group). The mean Physician Global Assessment was 2.1 in the psoriasis group, and the mean SCORing AD index was 33.3 in the AD group. The TOPICOP score was 16.0 in the psoriasis group and 18.8 in the AD group (p~=~0.10). The VAS score was 5.6 and 5.1 in the psoriasis and AD groups, respectively (p~=~0.18). The mean TOPICOP score was higher if the mother answered (p~
- Published
- 2017
- Full Text
- View/download PDF